Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association

Ndumele, Chiadi E., Rangaswami, Janani, Chow, Sheryl L., Neeland, Ian J., Tuttle, Katherine R., Khan, Sadiya S., Coresh, Josef, Mathew, Roy O. +22 more·2023·Circulation
DOI 10.1161/cir.0000000000001184

Cited by (1,000)

Items 101–200 of 1,000

  1. Exploring the nexus: The place of kidney diseases within the cardiovascular-kidney-metabolic syndrome spectrum
    Mehmet Kanbay, Mustafa Güldan, Laşin Özbek, Sidar Çöpür, Andreea Simona Covic, Adrian Constantin Covic · 2024 · European Journal of Internal Medicine
  2. Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome
    Maria A. Pabón, Gerasimos S Filippatos, Brian Lee Claggett, Michael Zi Miao, Akshay Suvas Desai, Pardeep S. Jhund, Alasdair David Henderson, MEIKE DANIELA BRINKER, Patrick Schloemer, Lucas H. Hofmeister et al. · 2025 · Journal of the American College of Cardiology
  3. Molecular Mechanisms of Type 2 Diabetes-Related Heart Disease and Therapeutic Insights
    Germán Camilo Giraldo, Alejandro Román-Gonzaléz, Felipe Cañas, Andrés M. García · 2025 · International Journal of Molecular Sciences
  4. In Vitro Modeling of Interorgan Crosstalk: Multi-Organ-on-a-Chip for Studying Cardiovascular-Kidney-Metabolic Syndrome
    Cody Juguilon, Ramak Khosravi, Milica Radisic, Joseph C. Wu · 2025 · Circulation Research
  5. Cardiovascular-Kidney-Metabolic Syndrome: Association with Adverse Events After Major Noncardiac Surgery
    Sebastian Roth, René M’Pembele, Purificacion Matute, Katarzyna Kotfis, Jan Larmann, Giovanna Lurati Buse · 2024 · Anesthesia & Analgesia
  6. Urban heat island impacts on mental health in middle-aged and older adults
    Yujia Bao, Yongxuan Li, Jiawei Gu, Chen Shen, Yuzheng Zhang, Xiaobei Deng, Lefei Han, Jinjun Ran · 2025 · Environment International
  7. Current type 2 diabetes guidelines: Individualized treatment and how to make the most of metformin
    Juliana C.N. Chan, Aimin Yang, Natural Hoi Sing Chu, Elaine Chow · 2024 · Diabetes Obesity and Metabolism
  8. Impact of Visceral and Hepatic Fat on Cardiometabolic Health
    Tasveer Khawaja, Matthew Nied, Abigail Wilgor, Ian J. Neeland · 2024 · Current Cardiology Reports
  9. Association between triglyceride glucose-body mass index and the trajectory of cardio-renal-metabolic multimorbidity: insights from multi-state modelling
    Haoxian Tang, Jingtao Huang, Xuan Zhang, Xiaojing Chen, Qinglong Yang, Nan Luo, Hanyuan Lin, Jianan Hong, Shiwan Wu, Cuihong Tian et al. · 2025 · Cardiovascular Diabetology
  10. SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiovascular–Kidney–Metabolic Syndrome
    Aryan Gajjar, Arvind Kumar Venkataramana Raju, Amar J. Gajjar, Mythili Menon, Syed Asfand Yar Shah, Sourbha S. Dani, Andrew M. Weinberg · 2025 · Biomedicines
  11. The global cardiovascular–liver–metabolic syndemic: epidemiology, trends and challenges
    Nicholas Chew, Anurag Mehta, Rachel Jia Ling Goh, Jaycie Koh, Yiming Chen, Bryan Chong, Mark Y. Chan, Muhammad Shahzeb Khan, Mark Dhinesh Muthiah, Javed Butler et al. · 2025 · Nature Reviews Cardiology
  12. Social Determinants of Health in Cardio-Oncology
    Foster Osei Baah, Sonal Sharda, Kimberly Ann Davidow, Sadhana Jackson, Daphney Kernizan, Joshua A. Jacobs, Yvonne Baumer, Corinna L. Schultz, Carissa Marrie Baker-Smith, Tiffany M. Powell‐Wiley · 2024 · JACC CardioOncology
  13. Associations of Concurrent Hypertension and Type 2 Diabetes With Mortality Outcomes: A Prospective Study of U.S. Adults
    Ye Yuan, Carmen R. Isasi, Tala Al‐Rousan, Arnab K. Ghosh, Pricila Honorato Mullachery, Priya Palta, Nour Makarem · 2025 · Diabetes Care
  14. Rising Prevalence of Cardiovascular-Kidney-Metabolic Syndrome in China, 2010-2019
    Daijun He, Xiao Zhang, Chenglong Li, Chao Yang, Mengting Yu, Jinwei Wang, Jiakang Huo, Bixia Gao, Minghui Zhao, Mei Zhang et al. · 2025 · Journal of the American College of Cardiology
  15. Research advances in the therapy of metabolic syndrome
    Zitian Lin, Luning Sun · 2024 · Frontiers in Pharmacology
  16. Human genetics identify convergent signals in mitochondrial LACTB-mediated lipid metabolism in cardiovascular-kidney-metabolic syndrome
    Li Shen, Hongbo Liu, Hailong Hu, Eunji Ha, Praveena Prasad, Brenita C. Jenkins, Ujjalkumar Subhash Das, Sarmistha Mukherjee, Kyosuke Shishikura, HU Ren-ming et al. · 2024 · Cell Metabolism
  17. CARDIAL-MS (CArdio-Renal-DIAbetes-Liver-Metabolic Syndrome): a new proposition for an integrated multisystem metabolic disease
    Amélio F. Godoy‐Matos, Cynthia Melissa Valério, Wellington Santana da Silva Júnior, João Marcello de Araújo Neto, Andrei Carvalho Sposito, José Hermógenes Rocco Suassuna · 2025 · Diabetology & Metabolic Syndrome
  18. Pathophysiology and emerging biomarkers of cardiovascular-renal-hepato-metabolic syndrome
    John Nzobokela, Lweendo Muchaili, Alick Mwambungu, Sepiso Kenias Masenga, Annet Kirabo · 2025 · Frontiers in Cardiovascular Medicine
  19. Physical exercise: a polypill against chronic kidney disease
    Pedro L. Valenzuela, Adrián Castillo‐García, Gonzalo Saco‐Ledo, Alejandro Santos‐Lozano, Alejandro Lucía · 2024 · Nephrology Dialysis Transplantation
  20. Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review
    Amedeo Lonardo · 2024 · Metabolism and Target Organ Damage
  21. Unravelling the cardio-renal-metabolic-foot connection in people with diabetes-related foot ulceration: a narrative review
    Nick S.R. Lan, Girish Dwivedi, P. Gerry Fegan, Frances L. Game, Emma Jane Hamilton · 2024 · Cardiovascular Diabetology
  22. Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in 3 Chinese Cohorts
    Qi Huang, Yufeng Li, Xianghai Zhou, Xiantong Zou, Linong Ji · 2025 · JACC Asia
  23. Long-term trends in the prevalence of cardiovascular-kidney-metabolic syndrome in South Korea, 2011–2021: a representative longitudinal serial study
    Yesol Yim, Jae Eun Lee, Yejun Son, Soeun Kim, Hojae Lee, Sooji Lee, Wonwoo Jang, Hanseul Cho, Hayeon Lee, Kyeongmin Lee et al. · 2025 · The Lancet Regional Health - Western Pacific
  24. The prevention and management of chronic kidney disease among patients with metabolic syndrome
    Doreen Zhu, Parminder K. Judge, Christoph Wanner, Richard Haynes, William Guy Herrington · 2025 · Kidney International
  25. Insulin resistance assessed by estimated glucose disposal rate predicts cardiovascular disease in stages 0–3 of cardiovascular-kidney-metabolic syndrome: a UK biobank cohort study
    Hao Zhang, Sizhuang Huang, Yanwen Fang, Haihua Zhang, Weixian Yang, Mengyue Yu · 2025 · Cardiovascular Diabetology
  26. Association between metabolic score for insulin resistance and future stroke risk in patients with cardiovascular-kidney-metabolic syndrome stages 0–3: a longitudinal analysis based on CHARLS
    Huihong Wu, Yang Zhou, Xinxing Lai, Bin Ma, Lu Ding, Xiaojie Zhu, Zixin Chen, Ziwang Liu · 2025 · Cardiovascular Diabetology
  27. Cardiovascular-Kidney-Metabolic Health Syndrome
    Nisha Bansal, Daniel E. Weiner, Mark J. Sarnak · 2024 · Journal of the American Society of Nephrology
  28. Life’s Essential 8 cardiovascular health, cardiovascular-kidney-metabolic syndrome stages, and incident cardiovascular events: a nationwide 10-year prospective cohort study in China
    Mian Li, Min Xu, Yi Ding, Hong Lin, Guijun Qin, Tiange Wang, Yu Hong Xu, Yu‐Hong Chen, Shuangyuan Wang, Zhiyun Zhao et al. · 2025 · Cardiovascular Diabetology
  29. MASLD, MASH, and the CKM Spectrum
    Faiez M. Zannad, Muhammad Shahzeb Khan, Nisha Bansal, Michael Böhm, Sven Francque, Nicolas Girerd, James L. Januzzi, Veronica Miller, Marie‐Ève Piché, Vlad Ratziu et al. · 2026 · Journal of the American College of Cardiology
  30. Cardiovascular-kidney-metabolic syndrome: Understanding the interconnections and the need for holistic intervention
    Jaber Husam Jaradat, Abdulqadir J. Nashwan · 2023 · Journal of Medicine Surgery and Public Health
  31. Adiposity, type 2 diabetes and atherosclerotic cardiovascular disease risk: Use and abuse of the body mass index
    Benoît J. Arsenault, André C. Carpentier, Paul Poirier, Jean‐Pierre Després · 2024 · Atherosclerosis
  32. Risk-directed management of chronic kidney disease
    Matthew F. Blum, Brendon Lange Neuen, Morgan Erika Grams · 2025 · Nature Reviews Nephrology
  33. Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the <scp>ORION</scp> ‐9, <scp>ORION</scp> ‐10 and <scp>ORION</scp> ‐11 Phase 3 randomized trials
    Leiter, Lawrence A., Raal, Frederick J., Schwartz, Gregory G., Koenig, Wolfgang, Ray, Kausik K., Landmesser, Ulf, Han, Jackie, Conde, Lorena Garcia, Wright, R. Scott · 2024 · Diabetes, Obesity and Metabolism
  34. Cardiovascular-Kidney-Metabolic Overlap in Heart Failure with Preserved Ejection Fraction: Cardiac Structure and Function, Clinical Outcomes, and Response to Sacubitril/Valsartan in PARAGON-HF
    Mats Christian Højbjerg Lassen, John W. Ostrominski, Brian Lee Claggett, Milton Packer, Michael R. Zile, Akshay Suvas Desai, Amil M. Shah, Maja Čikeš, Béla Péter Merkely, Mauro Gori et al. · 2024 · European Journal of Heart Failure
  35. Gender Disparities in the Association Between Educational Attainment and Cardiovascular-Kidney-Metabolic Syndrome: Cross-Sectional Study
    Yi Ding, Xianglin Wu, Qiuyu Cao, Jiaojiao Huang, Xiaoli Xu, Youjin Jiang, Yanan Huo, Qin Wan, Yingfen Qin, Ruying Hu et al. · 2024 · JMIR Public Health and Surveillance
  36. Cardiovascular, kidney, and metabolic health: an actionable vision for heart failure prevention
    John W. Ostrominski, ALICE Y.Y. CHENG, Adam J. Nelson, Brendon Lange Neuen, Naveed A. Sattar, Katherine R Tuttle, Muthiah Vaduganathan · 2025 · The Lancet
  37. Albuminuria-based universal screening for CKD should be implemented now in high-income countries
    Lucia Cordero, Alberto Ortíz · 2025 · Kidney International
  38. Melatonin Use during Pregnancy and Lactation Complicated by Oxidative Stress: Focus on Offspring’s Cardiovascular–Kidney–Metabolic Health in Animal Models
    You‐Lin Tain, Chien‐Ning Hsu · 2024 · Antioxidants
  39. Cardiovascular-kidney-metabolic syndrome definition and its role in the prevention, risk staging, and treatment. An opportunity for the Nephrology
    Aleix Cases, José Jesús Broseta, María Marqués, Secundino Cigarrán Guldris, Juan Carlos Julián Mauro, Roberto Alcázar Arroyo, Alberto Ortíz · 2024 · Nefrología (English Edition)
  40. Impact of DNA‐Methylation Age Acceleration on Long‐Term Mortality Among US Adults With Cardiovascular‐Kidney‐Metabolic Syndrome
    Shuang Wu, Jun Zhu, Si‐qi Lyu, Juan Wang, Xing‐hui Shao, Han Zhang, Ziyi Zhong, Hongyu Liu, Lihui Zheng, Yang Chen · 2025 · Journal of the American Heart Association
  41. The Cardiovascular-Kidney-Metabolic Health Framework
    Janani Rangaswami, Michael G. Shlipak, Roy O. Mathew, Chiadi E. Ndumele · 2025 · Clinical Journal of the American Society of Nephrology
  42. Relationship between nine triglyceride-glucose-related indices and cardiometabolic multimorbidity incidence in patients with cardiovascular-kidney-metabolic syndrome stage 0–3: a nationwide prospective cohort study
    Tonglong Jin, Xiaogang Tang, Yang Han, Haiqing Fan, Qi Qin, Hui Jiang, Zhaoyao Chen, Wenlei Li, Y u Zhu, Minghua Wu · 2026 · Cardiovascular Diabetology
  43. Cardiorenal Syndrome: An Evolutionary Appraisal
    James B. Young, Garabed Eknoyan · 2024 · Circulation Heart Failure
  44. Trends in Glucagon-Like Peptide-1 Receptor Agonist Social Media Posts Using Artificial Intelligence
    Javaid, Aamir, Baviriseaty, Sruthika, Javaid, Rehan, Zirikly, Ayah, Kukreja, Harshita, Kim, Chang H., Blaha, Michael J., Blumenthal, Roger S., Martin, Seth S., Marvel, Francoise A. · 2024 · JACC: Advances
  45. Cardiovascular and non‐renal complications of chronic kidney disease: Managing risk
    Peter R Rossing, Tine W. Hansen, Thomas Kümler · 2024 · Diabetes Obesity and Metabolism
  46. Precision Medicine for Cardiovascular Prevention and Population Health: A Bridge Too Far?
    Fernando Giugni, Jarett D. Berry, Amit Khera, Amil M. Shah, James A. de Lemos · 2024 · Circulation
  47. 2-Fold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis
    Christine Gyldenkerne, Johnny A. Kahlert, Pernille Gro Thrane, Kevin Kris Warnakula Olesen, Martin Bødtker Mortensen, Henrik Toft Sørensen, Reimar Wernich Thomsen, Michael Mæng · 2024 · Journal of the American College of Cardiology
  48. How ‘miracle’ weight‐loss semaglutide promises to change medicine but can we afford the expense?
    Ralf Weiskirchen, Amedeo Lonardo · 2025 · British Journal of Pharmacology
  49. Overall Sleep Quality Is Associated With Advanced Stages in Patients With Cardiovascular–Kidney–Metabolic Syndrome
    Dingyuan Tu, Jie Sun, Pengru Wang, Qiang Xu, Chaoqun Ma · 2025 · Journal of the American Heart Association
  50. A holistic approach to managing cardio-kidney metabolic syndrome: insights and recommendations from the Italian perspective
    Massimo Iacoviello, Mauro Gori, Giuseppe Grandaliano, Roberto Minutolo, Dario Pitocco, Roberto Trevisan · 2025 · Frontiers in Cardiovascular Medicine
  51. C-reactive protein–triglyceride glucose index and stroke risk in early cardiovascular-kidney-metabolic syndrome: a National cohort study
    Yinsong Xu, Shiqin Chen, Jingying Zhu, Qingyuan Wang, Weiyu Li, Gonghua Pan, Tian Lv, Youhua Huang, Wenbo Qu · 2025 · BMC Cardiovascular Disorders
  52. Tirzepatide compared with semaglutide and 10-year cardiovascular disease risk reduction in obesity: <i>post-hoc</i> analysis of the SURMOUNT-5 trial
    Mamas, Mamas A, Bays, Harold, Li, Runjia, Upadhyay, Navneet, Irani, Tanya, Senyucel, Cagri, Dunn, Julia P, Liu-Seifert, Hong · 2025 · European Heart Journal Open
  53. Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease
    Wright, R. Scott, Ray, Kausik K., Landmesser, Ulf, Koenig, Wolfgang, Raal, Frederick J., Leiter, Lawrence A., Conde, Lorena Garcia, Han, Jackie, Schwartz, Gregory G. · 2024 · Mayo Clinic Proceedings
  54. Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy
    Michał Nicze, Adrianna Dec, Maciej Borówka, Damian Krzyżak, Aleksandra Bołdys, Łukasz Bułdak, Bogusław Okopień · 2024 · International Journal of Molecular Sciences
  55. Advancing Cardiovascular, Kidney, and Metabolic Medicine: A Narrative Review of Insights and Innovations for the Future
    Kevin Fernando, Derek Leslie Connolly, Eimear Darcy, Marc Evans, William Hinchliffe, Patrick Holmes, William David Strain · 2025 · Diabetes Therapy
  56. Novel Cardiometabolic Medications in the Cardiovascular-Kidney-Metabolic Syndrome Era
    Neal Pohlman, Prem N Patel, Utibe R. Essien, Jingjing Tang, Joshua J. Joseph · 2025 · The Journal of Clinical Endocrinology & Metabolism
  57. Performance of the American Heart Association’s PREVENT risk score for cardiovascular risk prediction in a multiethnic population
    Roy O. Mathew, Sadiya S. Khan, Katherine R. Tuttle, Jennifer E. Ho, Dmitry Abramov, Sripal Bangalore, Mandeep S. Sidhu, Chiadi E. Ndumele, Tiffany M. Powell‐Wiley, Ian J. Neeland et al. · 2025 · Nature Medicine
  58. Association between different dimensions of the C-reactive protein-triglyceride-glucose index and future cardiovascular disease risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: a nationwide cohort study
    Jintao Chen, Liying Yan, Lei He, Weixue Wang · 2025 · Diabetology & Metabolic Syndrome
  59. The proteogenomic landscape of the human kidney and implications for cardio-kidney-metabolic health
    Daigoro Hirohama, João Fadista, Eunji Ha, Hongbo Liu, Amin Abedini, Jonathan L. Levinsohn, Allison Vassalotti, Li Zeng, Chenyu Li, Samer Mohandes et al. · 2025 · Nature Medicine
  60. Population‐Based Study on the Coexistence of Metabolic Dysfunction‐Associated Steatotic Liver Disease and Chronic Kidney Disease
    Rachel Sze Jen Goh, Jaycie Koh, Made Ayu Utami Intaran, Yip Han Chin, Gwyneth Kong, Bryan Chong, Jobelle Chia, Mark Y. Chan, Anurag Mehta, Mark Dhinesh Muthiah et al. · 2025 · Journal of the American Heart Association
  61. Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease
    Steven E. Nissen, Kathy Wolski, David A. D’Alessio, Govinda J. Weerakkody, Jacek I. Kiljanski, Russell J. Wiese, Imre J. Pavo, Bertrand Cariou, Stephen J Nicholls · 2026 · JAMA Cardiology
  62. Long-Term Physical Exercise for Preventing CKD in Older Adults
    Stein Ivar Hallan, Marius Altern Øvrehus, Michael G. Shlipak, O. Alison Potok, Solfrid Romundstad, Nils Petter Aspvik, Ulrik Wisløff, Joachim H. Ix, Dorthe Stensvold, Knut Asbjørn Rise Langlo · 2025 · Journal of the American Society of Nephrology
  63. Role of Residual Inflammation as a Risk Factor Across Cardiovascular-Kidney-Metabolic (CKM) Syndrome: Unpacking the Burden in People with Type 2 Diabetes
    Roya Ghafoury, Mojtaba Malek, Faramarz Ismail‐Beigi, Mohammad E. Khamseh · 2025 · Diabetes Therapy
  64. The impact of dietary interventions on cardiometabolic health
    Erind Gjermeni, Raluca Fiebiger, Linnaeus Bundalian, Antje Garten, Torsten Schöneberg, Diana Le Duc, Matthias Blüher · 2025 · Cardiovascular Diabetology
  65. Prevalence and long-term outcomes of NAFLD and cardiovascular-kidney-metabolic health in the United States
    Jian Liu, Lei Gao, Junlong Chen, Zhenghao Li, Wenhang Zhao, Shiwei Qin, Xuesong Wen, Dongying Zhang · 2025 · American Journal of Preventive Cardiology
  66. Association between the life's essential 8 health behaviors and prognosis in patients with advanced cardiovascular-kidney-metabolic syndrome
    Siyuan Tan, Jiabao Zhou, Fanqi Li, Gaoming Zeng, Na Liu, Tao Tu, Hao Chen, Qiuzhen Lin, Qiming Liu · 2025 · European Journal of Preventive Cardiology
  67. Association between estimated glucose disposal rate and prediction of cardiovascular disease risk among individuals with cardiovascular-kidney-metabolic syndrome stage 0–3: a nationwide prospective cohort study
    Jing Tian, Chen Hu, Yan Luo, Zhen Zhang, Shiqiang Xiong, Hanxiong Liu · 2025 · Diabetology & Metabolic Syndrome
  68. Atherogenic index of plasma and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 1 to 3: a longitudinal study
    Yu Zhang, Yue Song, Yinfei Lu, Tao Liu, Ping Yin · 2025 · Frontiers in Endocrinology
  69. Impact of cardiometabolic risk factors and its management on the reversion and progression of arterial stiffness
    Natalia Sofía De la Maza-Bustindui, Mariana León-Álvarez, Camila Ponce-Acosta, Kathya Paola Zarco-Morales, Carlos A. Fermín‐Martínez, Neftali Eduardo Antonio‐Villa, Omar Yaxmehen Bello‐Chavolla · 2025 · npj Cardiovascular Health
  70. Association of Atherogenic Index of Plasma With Stroke Risk in a Population With Cardiovascular‐Kidney‐Metabolic Syndrome Stages 0 to 3: The First Evidence From the China Health and Retirement Longitudinal Study
    Zhanao Liu, Dayong Zhou, Yaoliang Tang, Guijun Huo · 2025 · Journal of the American Heart Association
  71. Incorporation of Metabolic Dysfunction‐Associated Steatotic Liver Disease in the Health Stage of Cardiovascular‐Kidney‐Metabolic Syndrome Improves Predictive Ability for Coronary Artery Disease in a Japanese General Population
    Wataru Kawaharata, Marenao Tanaka, Tatsuya Sato, Yukinori Akiyama, Itaru Hosaka, Hiroki Aida, Rie Matsumori, Kei Nakata, Keitaro Nishizawa, Toru Suzuki et al. · 2025 · Journal of the American Heart Association
  72. Chronic Kidney Disease Prevalence and Awareness Among US Adults
    Jingyi Gong, Muthiah Vaduganathan, Rishi K. Wadhera · 2025 · JAMA Cardiology
  73. Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD)
    Qianqian Chen, Yixuan Zhu, Jingli Gao, Wenjing Ni, Shanghao Liu, Fajuan Rui, Xue Bai, Nan Geng, Rui Jin, Yuxiang Sun et al. · 2025 · Communications Medicine
  74. Association of various insulin resistance surrogate indices with aging acceleration and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: insights from CHARLS 2011–2020 data
    Shu-Shu Han, Qin Liu, Zhi-Ming Zeng, Ying Li, Ping-wei Li, Fang-Xiao Cheng, Pian Zhong, Jiang-Bo Li · 2026 · Cardiovascular Diabetology
  75. Amino Acids during Pregnancy and Offspring Cardiovascular–Kidney–Metabolic Health
    You‐Lin Tain, Chien‐Ning Hsu · 2024 · Nutrients
  76. Integrating Social Determinants of Health in the Management of Cardiovascular‐Kidney‐Metabolic Syndrome
    Ayana April-Sanders · 2024 · Journal of the American Heart Association
  77. Comparison of the efficacy and safety of GLP ‐1 receptor agonists on cardiovascular events and risk factors: A review and network meta‐analysis
    Xuedong An, WenJie Sun, Zhige Wen, Liyun Duan, YueHong Zhang, Xiaomin Kang, Hangyu Ji, Yuting Sun, Linlin Jiang, Xuefei Zhao et al. · 2025 · Diabetes Obesity and Metabolism
  78. Cardiovascular-kidney-metabolic syndrome and incidence of dementia among older adults
    Xiaqing Jiang, Amber L. Bahorik, Christina S. Dintica, Kristine S. Yaffe · 2025 · The Journal of Prevention of Alzheimer s Disease
  79. hs-CRP/HDL-C can predict the risk of all cause mortality in cardiovascular-kidney-metabolic syndrome stage 1-4 patients
    Fengjiao Han, Haiyang Guo, Hao Zhang, Yang Zheng · 2025 · Frontiers in Endocrinology
  80. Maintaining kidney health in aging societies: a JSN and ERA call to action
    Alberto Ortíz, Anneke Kramer, Ivan Rychlík, Masaomi Nangaku, Motoko Yanagita, Kitty J. Jager, Fergus John Caskey, Vianda S Stel, Naoki Kashihara, Takahiro Kuragano et al. · 2025 · Nephrology Dialysis Transplantation
  81. Social determinants of health (SDOH) associated with the risk of all-cause mortality and life expectancy in US adults with cardiovascular-kidney-metabolic syndrome: a NHANES 2001–2018 cohort study
    Qihang Yang, Pengfei Shi, Lanxia Pan, Zongqiang Huang · 2025 · BMC Cardiovascular Disorders
  82. Associations between insulin resistance indices and cardiovascular disease in older adults with cardiovascular-kidney-metabolic syndrome stage 0–3: The GOLD-Health cohort
    Menghe Wang, Weiquan Lin, Hui Liu, Zhengmin Min Qian, Jiamin Chen, Manting Rao, Qin Zhou, Zitong Zhuang, Liying Luo, Yingying Fang et al. · 2025 · Diabetes Research and Clinical Practice
  83. Lifestyle Interventions in Cardiovascular-Kidney-Metabolic Syndrome JACC: Advances Expert Panel
    Izza Shahid, Jerrin S. Philip, Eleonora Avenatti, Deepika Laddu, Michael David Shapiro, Amit Khera, Ambarish Pandey, Chiadi E. Ndumele, Martha Gulati, Khurram Nasir et al. · 2025 · JACC Advances
  84. Associations of Cardiovascular-Kidney-Metabolic Syndrome with Premature Mortality and Life Expectancies in US Adults: A Cohort Study
    Lubi Lei, Jingkuo Li, Wenbo Ding, Wei Wang, Yanwu Yu, Boxuan Pu, Yue Peng, Lihua Zhang, Yuan‐Lin Guo · 2025 · Cardiorenal Medicine
  85. Association between cardiovascular-kidney-metabolic syndrome, lifestyle, and all-cause and cause-specific mortality: a prospective cohort study
    Mingming Wang, Yanan Qiao, Ruilang Lin, Yongfu Yu, Min Zhao, Marie Standl, Costan G. Magnussen, Bo Xi · 2025 · EClinicalMedicine
  86. Temporal trends in the planetary health diet index and its association with cardiovascular, kidney, and metabolic diseases: A comprehensive analysis from global and individual perspectives
    Haoxian Tang, Xuan Zhang, Nan Luo, Jingtao Huang, Qinglong Yang, Hanyuan Lin, Mengyue Lin, Shiwan Wu, Jiasheng Wen, Jianan Hong et al. · 2025 · The journal of nutrition health & aging
  87. A united vision for cardiovascular–kidney–metabolic health
    Susan E. Quaggin, Benjamin L. Magod · 2024 · Nature Reviews Nephrology
  88. A novel model of cardiovascular–kidney–metabolic syndrome combining unilateral nephrectomy and high-salt–sugar–fat diet in mice
    Lucas Rannier Ribeiro Antonino Carvalho, Miho Shimari, Ariela Maína Boeder, Zhengbing Zhuge, Min Cai, Cecilia Leijding, Stefano Gastaldello, Andrei L. Kleschyov, Tomas A. Schiffer, Drielle D. Guimarães et al. · 2024 · Lab Animal
  89. Treatment strategies to reduce cardiovascular risk in persons with chronic kidney disease and Type 2 diabetes
    Faiez M. Zannad, Darren K. McGuire, Alberto Ortíz · 2024 · Journal of Internal Medicine
  90. Optimizing metabolic health with digital twins
    Chengxun Su, Peter Wang, Nigel Foo, Dean Ho · 2025 · npj Aging
  91. CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes
    Oliver Schnell, Jaime P. Almandoz, Lisa Anderson, Katharine D. Barnard-Kelly, Tadej Battelino, Matthias Blüher, Luca Busetto, Doina Catrinou, Antonio Ceriello, Xavier Cos et al. · 2025 · Cardiovascular Diabetology
  92. 10-Year and 30-Year Risks of Cardiovascular Disease in the U.S. Population
    Kamil F. Faridi, Devesh Malik, Mohammed Essa, Huanhuan Yang, Erica Sarah Spatz, Harlan M. Krumholz, Yuan Lu · 2025 · Journal of the American College of Cardiology
  93. Hepatic steatosis in cardiovascular–kidney–metabolic syndrome: fatty liver Index as a predictor of cardiovascular outcomes
    Byung Sik Kim, Hyun‐Jin Kim, Hasung Kim, Jungkuk Lee, Sang Bong Ahn, Jeong‐Hun Shin, Young Hyo Lim · 2025 · European Journal of Preventive Cardiology
  94. The Basics of Metabolic Dysfunction–Associated Steatotic Liver Disease for Cardiologists
    Muhammad Shahzeb Khan, Syed Sarmad Javaid, Amreen M. Dinani, Kara Wegermann, Ambarish Pandey, Ankeet S. Bhatt, Mark Dhinesh Muthiah, Harriette G.C. Van Spall, Faiez M. Zannad, Javed Butler et al. · 2025 · Journal of the American College of Cardiology
  95. Maternal Polyphenols and Offspring Cardiovascular–Kidney–Metabolic Health
    You‐Lin Tain, Chien‐Ning Hsu · 2024 · Nutrients
  96. Zero-shot Learning with Minimum Instruction to Extract Social Determinants and Family History from Clinical Notes using GPT Model
    Bhate, Neel Jitesh, Mittal, Ansh, He, Zhe, Luo, Xiao · 2023 · 2023 IEEE International Conference on Big Data (BigData)
  97. Impact of multimorbidity patterns on outcomes and treatment in patients with coronary artery disease
    Wen Zheng, Xin Huang, Wang Xiao, Min Suo, Yan Yan, Wei Gong, Hui Ai, Bin Que, Shaoping Nie · 2024 · European Heart Journal Open
  98. Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions
    Tariq Jamal Siddiqi, David Z.I. Cherney, Hasan Fareed Siddiqui, Tazeen H. Jafar, James L. Januzzi, Muhammad Shahzeb Khan, Adeera Levin, Nikolaus Marx, Janani Rangaswami, Jeffrey Moore Testani et al. · 2024 · Journal of the American Society of Nephrology
  99. What Is ‘Food Is Medicine,’ Really? Policy Considerations On The Road To Health Care Coverage
    Colin Schwartz, Alexa M. Wohrman, Emily J. Holubowich, Lisa D. Sanders, Kevin G. M. Volpp · 2025 · Health Affairs
  100. Association of estimated glucose disposition rate with aging acceleration and mortality risk in individuals with cardiovascular-kidney-metabolic syndrome: evidence from two large national population-based studies
    Mo‐Yao Tan, Zhen-Ni Jiang, Y. C. Li, Ziyu Li, Bin Niu · 2025 · Cardiovascular Diabetology